메뉴 건너뛰기




Volumn 124, Issue , 2016, Pages 63-81

Novel multi-target-directed ligands for Alzheimer's disease: Combining cholinesterase inhibitors and 5-HT6 receptor antagonists. Design, synthesis and biological evaluation

Author keywords

5 HT6 receptor antagonists; Acetylcholinesterase inhibitors; Alzheimer's disease; Butyrylcholinesterase inhibitors; Multi target directed ligands

Indexed keywords

ACETYLCHOLINESTERASE; CHOLINESTERASE; CHOLINESTERASE INHIBITOR; LIGAND; SEROTONIN 6 RECEPTOR; SEROTONIN RECEPTOR;

EID: 84983084983     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2016.08.016     Document Type: Article
Times cited : (78)

References (80)
  • 1
    • 84941331228 scopus 로고    scopus 로고
    • World Alzheimer report 2015: the global impact of dementia - an analysis of prevalence, incidence, cost and trends
    • [1] Prince, M., Wimo, A., Guerchet, M., Gemma-Claire, A., Wu, Y.-T., Prina, M., World Alzheimer report 2015: the global impact of dementia - an analysis of prevalence, incidence, cost and trends. Alzheimer's Dis. Int., 84, 2015, 10.1111/j.0963-7214.2004.00293.x.
    • (2015) Alzheimer's Dis. Int. , vol.84
    • Prince, M.1    Wimo, A.2    Guerchet, M.3    Gemma-Claire, A.4    Wu, Y.-T.5    Prina, M.6
  • 2
    • 84925880097 scopus 로고    scopus 로고
    • 2015 Alzheimer's disease facts and figures
    • [2] Alzheimer's Association, 2015 Alzheimer's disease facts and figures. Alzheimers. Dement. 11 (2015), 332–384, 10.1016/j.jalz.2015.02.003.
    • (2015) Alzheimers. Dement. , vol.11 , pp. 332-384
    • Alzheimer's Association1
  • 4
    • 79952544426 scopus 로고    scopus 로고
    • Neuropsychiatric symptoms and the risk of institutionalization and death: the aging, demographics, and memory study
    • [4] Okura, T., Plassman, B.L., Steffens, D.C., Llewellyn, D.J., Potter, G.G., Langa, K.M., Neuropsychiatric symptoms and the risk of institutionalization and death: the aging, demographics, and memory study. J. Am. Geriatr. Soc. 59 (2011), 473–481, 10.1111/j.1532-5415.2011.03314.x.
    • (2011) J. Am. Geriatr. Soc. , vol.59 , pp. 473-481
    • Okura, T.1    Plassman, B.L.2    Steffens, D.C.3    Llewellyn, D.J.4    Potter, G.G.5    Langa, K.M.6
  • 5
    • 84914815546 scopus 로고    scopus 로고
    • Cognitive and neuropsychiatric impairments in Alzheimer's disease: current treatment strategies
    • [5] Borisovskaya, A., Pascualy, M., Borson, S., Cognitive and neuropsychiatric impairments in Alzheimer's disease: current treatment strategies. Curr. Psychiatry Rep. 16 (2014), 1–9, 10.1007/s11920-014-0470-z.
    • (2014) Curr. Psychiatry Rep. , vol.16 , pp. 1-9
    • Borisovskaya, A.1    Pascualy, M.2    Borson, S.3
  • 6
    • 0033920019 scopus 로고    scopus 로고
    • The role of cholinergic agents in the management of behavioural disturbances in Alzheimer's disease
    • [6] Cummings, J.L., The role of cholinergic agents in the management of behavioural disturbances in Alzheimer's disease. Int. J. Neuropsychopharmacol. 3 (2000), 21–29, 10.1017/S1461145700001917.
    • (2000) Int. J. Neuropsychopharmacol. , vol.3 , pp. 21-29
    • Cummings, J.L.1
  • 7
    • 84983032987 scopus 로고    scopus 로고
    • Public Health Advisory: Deaths with Antipsychotics in Elderly Patients with Behavioral Disturbances, Center for Drug Evaluation and Research, Rockville, MD
    • Available at: (accessed 04.04.16.)
    • [7] U.S. Food and Drug Administration, Public Health Advisory: Deaths with Antipsychotics in Elderly Patients with Behavioral Disturbances, Center for Drug Evaluation and Research, Rockville, MD. 2005 Available at: http://www.fda.gov/drugs/drugsafety/postmarketdrugsafetyinformationforpatientsandproviders/ucm053171 (accessed 04.04.16.).
    • (2005)
    • U.S. Food and Drug Administration1
  • 8
    • 84983029883 scopus 로고    scopus 로고
    • Information on Conventional Antipsychotics, Center for Drug Evaluation and Research, Rockville, MD
    • Available at: accessed 04.04.16.
    • [8] U.S. Food and Drug Administration, Information on Conventional Antipsychotics, Center for Drug Evaluation and Research, Rockville, MD. 2008 Available at: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm107211.htm accessed 04.04.16.
    • (2008)
    • U.S. Food and Drug Administration1
  • 9
    • 0011162190 scopus 로고
    • Selective loss of central cholinergic neurons in Alzheimer's disease
    • [9] Davies, P., Maloney, A.J., Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet, 2, 1976, 1403, 10.1016/S0140-6736(76)91936-X.
    • (1976) Lancet , vol.2 , pp. 1403
    • Davies, P.1    Maloney, A.J.2
  • 10
    • 79955738773 scopus 로고    scopus 로고
    • The history of the cholinergic hypothesis, Behav
    • [10] Contestabile, A., The history of the cholinergic hypothesis, Behav. Brain Res. 221 (2011), 334–340, 10.1016/j.bbr.2009.12.044.
    • (2011) Brain Res. , vol.221 , pp. 334-340
    • Contestabile, A.1
  • 11
    • 80052921123 scopus 로고    scopus 로고
    • Alzheimer's disease: emerging trends in small molecule therapies
    • [11] Mohamed, T., Rao, P.P.N., Alzheimer's disease: emerging trends in small molecule therapies. Curr. Med. Chem. 18 (2011), 4299–4320, 10.2174/092986711797200435.
    • (2011) Curr. Med. Chem. , vol.18 , pp. 4299-4320
    • Mohamed, T.1    Rao, P.P.N.2
  • 12
    • 84860891561 scopus 로고    scopus 로고
    • Cholinesterase inhibitors and memantine for symptomatic treatment of dementia
    • e2986–e2986
    • [12] Rodda, J., Carter, J., Cholinesterase inhibitors and memantine for symptomatic treatment of dementia. BMJ, 344, 2012, 10.1136/bmj.e2986 e2986–e2986.
    • (2012) BMJ , vol.344
    • Rodda, J.1    Carter, J.2
  • 13
    • 27144524511 scopus 로고    scopus 로고
    • Effect of rivastigmine in the treatment of behavioral disturbances associated with dementia: review of neuropsychiatric impairment in Alzheimer's disease
    • [13] Grossberg, G.T., Effect of rivastigmine in the treatment of behavioral disturbances associated with dementia: review of neuropsychiatric impairment in Alzheimer's disease. Curr. Med. Res. Opin. 21 (2005), 1631–1639, 10.1185/030079905X65402.
    • (2005) Curr. Med. Res. Opin. , vol.21 , pp. 1631-1639
    • Grossberg, G.T.1
  • 14
    • 84901826580 scopus 로고    scopus 로고
    • Serotonergic therapies for cognitive symptoms in Alzheimer's disease: rationale and current status
    • [14] Ramirez, M.J., Lai, M.K.P., Tordera, R.M., Francis, P.T., Serotonergic therapies for cognitive symptoms in Alzheimer's disease: rationale and current status. Drugs 74 (2014), 729–736, 10.1007/s40265-014-0217-5.
    • (2014) Drugs , vol.74 , pp. 729-736
    • Ramirez, M.J.1    Lai, M.K.P.2    Tordera, R.M.3    Francis, P.T.4
  • 16
    • 84920128903 scopus 로고    scopus 로고
    • Serotonin 5-HT6 receptor antagonists for the treatment of cognitive deficiency in Alzheimer's disease
    • [16] Benhamú, B., Martín-Fontecha, M., Vázquez-Villa, H., Pardo, L., López-Rodríguez, M.L., Serotonin 5-HT6 receptor antagonists for the treatment of cognitive deficiency in Alzheimer's disease. J. Med. Chem. 57 (2014), 7160–7181, 10.1021/jm5003952.
    • (2014) J. Med. Chem. , vol.57 , pp. 7160-7181
    • Benhamú, B.1    Martín-Fontecha, M.2    Vázquez-Villa, H.3    Pardo, L.4    López-Rodríguez, M.L.5
  • 17
    • 80052184853 scopus 로고    scopus 로고
    • Role of serotonin in Alzheimer's disease: a new therapeutic target?
    • [17] Geldenhuys, W.J., Van der Schyf, C.J., Role of serotonin in Alzheimer's disease: a new therapeutic target?. CNS Drugs 25 (2011), 765–781, 10.2165/11590190-000000000-00000.
    • (2011) CNS Drugs , vol.25 , pp. 765-781
    • Geldenhuys, W.J.1    Van der Schyf, C.J.2
  • 19
  • 21
    • 28044437798 scopus 로고    scopus 로고
    • 5-HT6 receptors: a novel target for cognitive enhancement
    • [21] Mitchell, E.S., Neumaier, J.F., 5-HT6 receptors: a novel target for cognitive enhancement. Pharmacol. Ther. 108 (2005), 320–333, 10.1016/j.pharmthera.2005.05.001.
    • (2005) Pharmacol. Ther. , vol.108 , pp. 320-333
    • Mitchell, E.S.1    Neumaier, J.F.2
  • 22
    • 53449090731 scopus 로고    scopus 로고
    • An update on the role of the 5-hydroxytryptamine6 receptor in cognitive function
    • [22] Fone, K.C.F., An update on the role of the 5-hydroxytryptamine6 receptor in cognitive function. Neuropharmacology 55 (2008), 1015–1022, 10.1016/j.neuropharm.2008.06.061.
    • (2008) Neuropharmacology , vol.55 , pp. 1015-1022
    • Fone, K.C.F.1
  • 23
    • 0037468873 scopus 로고    scopus 로고
    • Influence of the 5-HT6 receptor on acetylcholine release in the cortex: pharmacological characterization of 4-(2-bromo-6-pyrrolidin-1-ylpyridine-4-sulfonyl)phenylamine, a potent and selective 5-HT6 receptor antagonist
    • [23] Riemer, C., Borroni, E., Levet-Trafit, B., Martin, J.R., Poli, S., Porter, R.H.P., Bös, M., Influence of the 5-HT6 receptor on acetylcholine release in the cortex: pharmacological characterization of 4-(2-bromo-6-pyrrolidin-1-ylpyridine-4-sulfonyl)phenylamine, a potent and selective 5-HT6 receptor antagonist. J. Med. Chem. 46 (2003), 1273–1276, 10.1021/jm021085c.
    • (2003) J. Med. Chem. , vol.46 , pp. 1273-1276
    • Riemer, C.1    Borroni, E.2    Levet-Trafit, B.3    Martin, J.R.4    Poli, S.5    Porter, R.H.P.6    Bös, M.7
  • 24
    • 33748751956 scopus 로고    scopus 로고
    • Lack of localization of 5-HT6 receptors on cholinergic neurons: implication of multiple neurotransmitter systems in 5-HT6 receptor-mediated acetylcholine release
    • [24] Marcos, B., Gil-Bea, F.J., Hirst, W.D., García-Alloza, M., Ramírez, M.J., Lack of localization of 5-HT6 receptors on cholinergic neurons: implication of multiple neurotransmitter systems in 5-HT6 receptor-mediated acetylcholine release. Eur. J. Neurosci. 24 (2006), 1299–1306, 10.1111/j.1460-9568.2006.05003.x.
    • (2006) Eur. J. Neurosci. , vol.24 , pp. 1299-1306
    • Marcos, B.1    Gil-Bea, F.J.2    Hirst, W.D.3    García-Alloza, M.4    Ramírez, M.J.5
  • 25
    • 0034782825 scopus 로고    scopus 로고
    • The 5-HT6 receptor antagonist SB-271046 selectively enhances excitatory neurotransmission in the rat frontal cortex and hippocampus
    • [25] Dawson, L.A., Nguyen, H.Q., Li, P., The 5-HT6 receptor antagonist SB-271046 selectively enhances excitatory neurotransmission in the rat frontal cortex and hippocampus. Neuropsychopharmacology 25 (2001), 662–668, 10.1016/S0893-133X(01)00265-2.
    • (2001) Neuropsychopharmacology , vol.25 , pp. 662-668
    • Dawson, L.A.1    Nguyen, H.Q.2    Li, P.3
  • 27
    • 84862856870 scopus 로고    scopus 로고
    • The Serotonin-6 receptor as a novel therapeutic target
    • [27] Yun, H.-M., Rhim, H., The Serotonin-6 receptor as a novel therapeutic target. Exp. Neurobiol., 20, 2011, 159, 10.5607/en.2011.20.4.159.
    • (2011) Exp. Neurobiol. , vol.20 , pp. 159
    • Yun, H.-M.1    Rhim, H.2
  • 28
    • 0034742606 scopus 로고    scopus 로고
    • A role for 5-ht6 receptors in retention of spatial learning in the Morris water maze
    • [28] Woolley, M., Bentley, J., Sleight, A., Marsden, C., Fone, K.C., A role for 5-ht6 receptors in retention of spatial learning in the Morris water maze. Neuropharmacology 41 (2001), 210–219, 10.1016/S0028-3908(01)00056-9.
    • (2001) Neuropharmacology , vol.41 , pp. 210-219
    • Woolley, M.1    Bentley, J.2    Sleight, A.3    Marsden, C.4    Fone, K.C.5
  • 29
    • 70349734329 scopus 로고    scopus 로고
    • Activation of the 5-HT6 receptor attenuates long-term potentiation and facilitates GABAergic neurotransmission in rat hippocampus
    • [29] West, P.J., Marcy, V.R., Marino, M.J., Schaffhauser, H., Activation of the 5-HT6 receptor attenuates long-term potentiation and facilitates GABAergic neurotransmission in rat hippocampus. Neuroscience 164 (2009), 692–701, 10.1016/j.neuroscience.2009.07.061.
    • (2009) Neuroscience , vol.164 , pp. 692-701
    • West, P.J.1    Marcy, V.R.2    Marino, M.J.3    Schaffhauser, H.4
  • 30
    • 0037343932 scopus 로고    scopus 로고
    • Neurotransmitter systems involved in learning and memory in the rat: a meta-analysis based on studies of four behavioral tasks
    • [30] Myhrer, T., Neurotransmitter systems involved in learning and memory in the rat: a meta-analysis based on studies of four behavioral tasks. Brain Res. Rev. 41 (2003), 268–287, 10.1016/S0165-0173(02)00268-0.
    • (2003) Brain Res. Rev. , vol.41 , pp. 268-287
    • Myhrer, T.1
  • 31
    • 77957983253 scopus 로고    scopus 로고
    • Potential role of the 5-HT6 receptor in depression and anxiety: an overview of preclinical data
    • [31] Wesołowska, A., Potential role of the 5-HT6 receptor in depression and anxiety: an overview of preclinical data. Pharmacol. Rep. 62 (2010), 564–577, 10.1016/S1734-1140(10)70315-7.
    • (2010) Pharmacol. Rep. , vol.62 , pp. 564-577
    • Wesołowska, A.1
  • 32
    • 84931828604 scopus 로고    scopus 로고
    • Serotonergic 5-HT6 receptor antagonists: heterocyclic chemistry and potential therapeutic significance
    • [32] Bali, A., Singh, S., Serotonergic 5-HT6 receptor antagonists: heterocyclic chemistry and potential therapeutic significance. Curr. Top. Med. Chem. 15 (2015), 1643–1662, 10.2174/1568026615666150427110420.
    • (2015) Curr. Top. Med. Chem. , vol.15 , pp. 1643-1662
    • Bali, A.1    Singh, S.2
  • 33
    • 46749118971 scopus 로고    scopus 로고
    • 5-HT6 receptor antagonists as novel cognitive enhancing agents for Alzheimer's disease
    • [33] Upton, N., Chuang, T.T., Hunter, A.J., Virley, D.J., 5-HT6 receptor antagonists as novel cognitive enhancing agents for Alzheimer's disease. Neurotherapeutics 5 (2008), 458–469, 10.1016/j.nurt.2008.05.008.
    • (2008) Neurotherapeutics , vol.5 , pp. 458-469
    • Upton, N.1    Chuang, T.T.2    Hunter, A.J.3    Virley, D.J.4
  • 34
    • 84907995546 scopus 로고    scopus 로고
    • Safety and efficacy of idalopirdine, a 5-HT6 receptor antagonist, in patients with moderate Alzheimer's disease (LADDER): a randomised, double-blind, placebo-controlled phase 2 trial
    • [34] Wilkinson, D., Windfeld, K., Colding-Jørgensen, E., Safety and efficacy of idalopirdine, a 5-HT6 receptor antagonist, in patients with moderate Alzheimer's disease (LADDER): a randomised, double-blind, placebo-controlled phase 2 trial. Lancet. Neurol. 13 (2014), 1092–1099, 10.1016/S1474-4422(14)70198-X.
    • (2014) Lancet. Neurol. , vol.13 , pp. 1092-1099
    • Wilkinson, D.1    Windfeld, K.2    Colding-Jørgensen, E.3
  • 35
    • 27144449695 scopus 로고    scopus 로고
    • Designed multiple ligands. An emerging drug discovery paradigm
    • [35] Morphy, R., Rankovic, Z., Designed multiple ligands. An emerging drug discovery paradigm. J. Med. Chem. 48 (2005), 6523–6543, 10.1021/jm058225d.
    • (2005) J. Med. Chem. , vol.48 , pp. 6523-6543
    • Morphy, R.1    Rankovic, Z.2
  • 36
    • 3242794178 scopus 로고    scopus 로고
    • From magic bullets to designed multiple ligands
    • [36] Morphy, R., Kay, C., Rankovic, Z., From magic bullets to designed multiple ligands. Drug Discov. Today 9 (2004), 641–651, 10.1016/S1359-6446(04)03163-0.
    • (2004) Drug Discov. Today , vol.9 , pp. 641-651
    • Morphy, R.1    Kay, C.2    Rankovic, Z.3
  • 37
    • 84928684146 scopus 로고    scopus 로고
    • Recent development of multifunctional agents as potential drug candidates for the treatment of Alzheimer's disease
    • [37] Guzior, N., Więckowska, A., Panek, D., Malawska, B., Recent development of multifunctional agents as potential drug candidates for the treatment of Alzheimer's disease. Curr. Med. Chem. 22 (2015), 373–404, 10.2174/0929867321666141106122628.
    • (2015) Curr. Med. Chem. , vol.22 , pp. 373-404
    • Guzior, N.1    Więckowska, A.2    Panek, D.3    Malawska, B.4
  • 38
    • 84937758940 scopus 로고    scopus 로고
    • Synthesis of new N-benzylpiperidine derivatives as cholinesterase inhibitors with β-amyloid anti-aggregation properties and beneficial effects on memory in vivo
    • [38] Więckowska, A., Więckowski, K., Bajda, M., Brus, B., Sałat, K., Czerwińska, P., Gobec, S., Filipek, B., Malawska, B., Synthesis of new N-benzylpiperidine derivatives as cholinesterase inhibitors with β-amyloid anti-aggregation properties and beneficial effects on memory in vivo. Bioorg. Med. Chem. 23 (2015), 2445–2457, 10.1016/j.bmc.2015.03.051.
    • (2015) Bioorg. Med. Chem. , vol.23 , pp. 2445-2457
    • Więckowska, A.1    Więckowski, K.2    Bajda, M.3    Brus, B.4    Sałat, K.5    Czerwińska, P.6    Gobec, S.7    Filipek, B.8    Malawska, B.9
  • 40
    • 78649329701 scopus 로고    scopus 로고
    • Novel alkyl- and arylcarbamate derivatives with N-benzylpiperidine and N-benzylpiperazine moieties as cholinesterases inhibitors
    • [40] Więckowska, A., Bajda, M., Guzior, N., Malawska, B., Novel alkyl- and arylcarbamate derivatives with N-benzylpiperidine and N-benzylpiperazine moieties as cholinesterases inhibitors. Eur. J. Med. Chem. 45 (2010), 5602–5611, 10.1016/j.ejmech.2010.09.010.
    • (2010) Eur. J. Med. Chem. , vol.45 , pp. 5602-5611
    • Więckowska, A.1    Bajda, M.2    Guzior, N.3    Malawska, B.4
  • 43
    • 84983063884 scopus 로고    scopus 로고
    • 1-Aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 Ligands
    • US Application WO0236562 (A2)
    • [43] Kelly, M., Cole, D., 1-Aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 Ligands. 2002 US Application WO0236562 (A2).
    • (2002)
    • Kelly, M.1    Cole, D.2
  • 44
    • 0034284410 scopus 로고    scopus 로고
    • Huperzine A and tacrine attenuate β-amyloid peptide-induced oxidative injury
    • 5<564::AID-JNR11>3.0.CO;2-X
    • [44] Xiao, X.Q., Wang, R., Tang, X.C., Huperzine A and tacrine attenuate β-amyloid peptide-induced oxidative injury. J. Neurosci. Res. 61 (2000), 564–569, 10.1002/1097-4547(20000901)61 5<564::AID-JNR11>3.0.CO;2-X.
    • (2000) J. Neurosci. Res. , vol.61 , pp. 564-569
    • Xiao, X.Q.1    Wang, R.2    Tang, X.C.3
  • 45
    • 35748931165 scopus 로고    scopus 로고
    • A new acetylcholinesterase inhibitor with anti-PAF activity modulates oxidative stress and pro-inflammatory mediators release in stimulated RAW 264.7 macrophage cells. Comparison with tacrine
    • [45] Ezoulin, M.J.M., Liu, Z., Dutertre-Catella, H., Wu, G., Dong, C.Z., Heymans, F., Ombetta, J.E., Rat, P., Massicot, F., A new acetylcholinesterase inhibitor with anti-PAF activity modulates oxidative stress and pro-inflammatory mediators release in stimulated RAW 264.7 macrophage cells. Comparison with tacrine. Int. Immunopharmacol. 7 (2007), 1685–1694, 10.1016/j.intimp.2007.08.023.
    • (2007) Int. Immunopharmacol. , vol.7 , pp. 1685-1694
    • Ezoulin, M.J.M.1    Liu, Z.2    Dutertre-Catella, H.3    Wu, G.4    Dong, C.Z.5    Heymans, F.6    Ombetta, J.E.7    Rat, P.8    Massicot, F.9
  • 46
    • 84939200016 scopus 로고    scopus 로고
    • Novel levetiracetam derivatives that are effective against the Alzheimer-like phenotype in mice: synthesis, in vitro, ex vivo, and in vivo efficacy studies
    • [46] Sola, I., Aso, E., Frattini, D., López-González, I., Espargaró, A., Sabaté, R., Di Pietro, O., Luque, F.J., Clos, M.V., Ferrer, I., Muñoz-Torrero, D., Novel levetiracetam derivatives that are effective against the Alzheimer-like phenotype in mice: synthesis, in vitro, ex vivo, and in vivo efficacy studies. J. Med. Chem. 58 (2015), 6018–6032, 10.1021/acs.jmedchem.5b00624.
    • (2015) J. Med. Chem. , vol.58 , pp. 6018-6032
    • Sola, I.1    Aso, E.2    Frattini, D.3    López-González, I.4    Espargaró, A.5    Sabaté, R.6    Di Pietro, O.7    Luque, F.J.8    Clos, M.V.9    Ferrer, I.10    Muñoz-Torrero, D.11
  • 47
    • 84906888262 scopus 로고    scopus 로고
    • Synthesis and biological evaluation of novel tacrine derivatives and tacrine-coumarin hybrids as cholinesterase inhibitors
    • [47] Hamulakova, S., Janovec, L., Hrabinova, M., Spilovska, K., Korabecny, J., Kristian, P., Kuca, K., Imrich, J., Synthesis and biological evaluation of novel tacrine derivatives and tacrine-coumarin hybrids as cholinesterase inhibitors. J. Med. Chem. 57 (2014), 7073–7084, 10.1021/jm5008648.
    • (2014) J. Med. Chem. , vol.57 , pp. 7073-7084
    • Hamulakova, S.1    Janovec, L.2    Hrabinova, M.3    Spilovska, K.4    Korabecny, J.5    Kristian, P.6    Kuca, K.7    Imrich, J.8
  • 49
    • 84856914519 scopus 로고    scopus 로고
    • New tacrine-4-oxo-4H-chromene hybrids as multifunctional agents for the treatment of Alzheimer's disease, with cholinergic, antioxidant, and β-amyloid-reducing properties
    • [49] Fernández-Bachiller, M.I., Pérez, C., Monjas, L., Rademann, J., Rodríguez-Franco, M.I., New tacrine-4-oxo-4H-chromene hybrids as multifunctional agents for the treatment of Alzheimer's disease, with cholinergic, antioxidant, and β-amyloid-reducing properties. J. Med. Chem. 55 (2012), 1303–1317, 10.1021/jm201460y.
    • (2012) J. Med. Chem. , vol.55 , pp. 1303-1317
    • Fernández-Bachiller, M.I.1    Pérez, C.2    Monjas, L.3    Rademann, J.4    Rodríguez-Franco, M.I.5
  • 51
    • 84925444000 scopus 로고    scopus 로고
    • Multi-target tacrine-coumarin hybrids: cholinesterase and monoamine oxidase B inhibition properties against Alzheimer's disease
    • [51] Xie, S.-S., Wang, X., Jiang, N., Yu, W., Wang, K.D.G., Lan, J.-S., Li, Z.-R., Kong, L.-Y., Multi-target tacrine-coumarin hybrids: cholinesterase and monoamine oxidase B inhibition properties against Alzheimer's disease. Eur. J. Med. Chem. 95 (2015), 153–165, 10.1016/j.ejmech.2015.03.040.
    • (2015) Eur. J. Med. Chem. , vol.95 , pp. 153-165
    • Xie, S.-S.1    Wang, X.2    Jiang, N.3    Yu, W.4    Wang, K.D.G.5    Lan, J.-S.6    Li, Z.-R.7    Kong, L.-Y.8
  • 53
    • 84861048527 scopus 로고    scopus 로고
    • Tacrine-ferulic acid-nitric oxide (NO) donor trihybrids as potent, multifunctional acetyl- and butyrylcholinesterase inhibitors
    • [53] Chen, Y., Sun, J., Fang, L., Liu, M., Peng, S., Liao, H., Lehmann, J., Zhang, Y., Tacrine-ferulic acid-nitric oxide (NO) donor trihybrids as potent, multifunctional acetyl- and butyrylcholinesterase inhibitors. J. Med. Chem. 55 (2012), 4309–4321, 10.1021/jm300106z.
    • (2012) J. Med. Chem. , vol.55 , pp. 4309-4321
    • Chen, Y.1    Sun, J.2    Fang, L.3    Liu, M.4    Peng, S.5    Liao, H.6    Lehmann, J.7    Zhang, Y.8
  • 55
    • 60549106063 scopus 로고    scopus 로고
    • Design, synthesis, and evaluation of benzophenone derivatives as novel acetylcholinesterase inhibitors
    • [55] Belluti, F., Piazzi, L., Bisi, A., Gobbi, S., Bartolini, M., Cavalli, A., Valenti, P., Rampa, A., Design, synthesis, and evaluation of benzophenone derivatives as novel acetylcholinesterase inhibitors. Eur. J. Med. Chem. 44 (2009), 1341–1348, 10.1016/j.ejmech.2008.02.035.
    • (2009) Eur. J. Med. Chem. , vol.44 , pp. 1341-1348
    • Belluti, F.1    Piazzi, L.2    Bisi, A.3    Gobbi, S.4    Bartolini, M.5    Cavalli, A.6    Valenti, P.7    Rampa, A.8
  • 56
    • 84882514623 scopus 로고    scopus 로고
    • Synthesis, pharmacological assessment, and molecular modeling of 6-chloro-pyridonepezils: new dual AChE inhibitors as potential drugs for the treatment of Alzheimer's disease
    • [56] Samadi, A., de la Fuente Revenga, M., Pérez, C., Iriepa, I., Moraleda, I., Rodríguez-Franco, M.I., Marco-Contelles, J., Synthesis, pharmacological assessment, and molecular modeling of 6-chloro-pyridonepezils: new dual AChE inhibitors as potential drugs for the treatment of Alzheimer's disease. Eur. J. Med. Chem. 67 (2013), 64–74, 10.1016/j.ejmech.2013.06.021.
    • (2013) Eur. J. Med. Chem. , vol.67 , pp. 64-74
    • Samadi, A.1    de la Fuente Revenga, M.2    Pérez, C.3    Iriepa, I.4    Moraleda, I.5    Rodríguez-Franco, M.I.6    Marco-Contelles, J.7
  • 57
    • 84921689816 scopus 로고    scopus 로고
    • Development of multifunctional, heterodimeric isoindoline-1,3-dione derivatives as cholinesterase and β-amyloid aggregation inhibitors with neuroprotective properties
    • [57] Guzior, N., Bajda, M., Skrok, M., Kurpiewska, K., Lewiński, K., Brus, B., Pišlar, A., Kos, J., Gobec, S., Malawska, B., Development of multifunctional, heterodimeric isoindoline-1,3-dione derivatives as cholinesterase and β-amyloid aggregation inhibitors with neuroprotective properties. Eur. J. Med. Chem. 92 (2015), 738–749, 10.1016/j.ejmech.2015.01.027.
    • (2015) Eur. J. Med. Chem. , vol.92 , pp. 738-749
    • Guzior, N.1    Bajda, M.2    Skrok, M.3    Kurpiewska, K.4    Lewiński, K.5    Brus, B.6    Pišlar, A.7    Kos, J.8    Gobec, S.9    Malawska, B.10
  • 58
    • 84055217642 scopus 로고    scopus 로고
    • Synthesis, biological evaluation, and molecular modeling of donepezil and N-[(5-(benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease
    • [58] Bolea, I., Juárez-Jiménez, J., de los Ríos, C., Chioua, M., Pouplana, R., Luque, F.J., Unzeta, M., Marco-Contelles, J., Samadi, A., Synthesis, biological evaluation, and molecular modeling of donepezil and N-[(5-(benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease. J. Med. Chem. 54 (2011), 8251–8270, 10.1021/jm200853t.
    • (2011) J. Med. Chem. , vol.54 , pp. 8251-8270
    • Bolea, I.1    Juárez-Jiménez, J.2    de los Ríos, C.3    Chioua, M.4    Pouplana, R.5    Luque, F.J.6    Unzeta, M.7    Marco-Contelles, J.8    Samadi, A.9
  • 59
    • 0032458505 scopus 로고    scopus 로고
    • Three-dimensional structure of a complex of E2020 with acetylcholinesterase from Torpedo californica
    • [59] Kryger, G., Silman, I., Sussman, J.L., Three-dimensional structure of a complex of E2020 with acetylcholinesterase from Torpedo californica. J. Physiol. 92 (1998), 191–194, 10.1016/S0928-4257(98)80008-9.
    • (1998) J. Physiol. , vol.92 , pp. 191-194
    • Kryger, G.1    Silman, I.2    Sussman, J.L.3
  • 60
    • 0033103478 scopus 로고    scopus 로고
    • Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs
    • [60] Kryger, G., Silman, I., Sussman, J.L., Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs. Structure 7 (1999), 297–307, 10.1016/S0969-2126(99)80040-9.
    • (1999) Structure , vol.7 , pp. 297-307
    • Kryger, G.1    Silman, I.2    Sussman, J.L.3
  • 61
    • 33644811612 scopus 로고
    • A new and rapid colorimetric determination of acetylcholinesterase activity
    • [61] Ellman, G.L., Courtney, K.D., Andres, V., Featherstone, R.M., A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7 (1961), 88–95, 10.1016/0006-2952(61)90145-9.
    • (1961) Biochem. Pharmacol. , vol.7 , pp. 88-95
    • Ellman, G.L.1    Courtney, K.D.2    Andres, V.3    Featherstone, R.M.4
  • 62
    • 84962359573 scopus 로고    scopus 로고
    • High throughput artificial membrane permeability assay for blood–brain barrier
    • [62] Di, L., Kerns, E.H., Fan, K., McConnell, O.J., Carter, G.T., High throughput artificial membrane permeability assay for blood–brain barrier. Eur. J. Med. Chem. 38 (2003), 223–232, 10.1016/S0223-5234(03)00012-6.
    • (2003) Eur. J. Med. Chem. , vol.38 , pp. 223-232
    • Di, L.1    Kerns, E.H.2    Fan, K.3    McConnell, O.J.4    Carter, G.T.5
  • 63
    • 0021988656 scopus 로고
    • The effects of centrally acting adrenergic agonists on temperature and on explorative and motor behaviour. Relation with effects on quasi-morphine withdrawal behaviour
    • (accessed 04.04.16.)
    • [63] Van der Laan, J.W., Van Veenendaal, W., Voorthuis, P., Weick, G., Hillen, F.C., The effects of centrally acting adrenergic agonists on temperature and on explorative and motor behaviour. Relation with effects on quasi-morphine withdrawal behaviour. Eur. J. Pharmacol. 107 (1985), 367–373 http://www.ncbi.nlm.nih.gov/pubmed/2858393 (accessed 04.04.16.).
    • (1985) Eur. J. Pharmacol. , vol.107 , pp. 367-373
    • Van der Laan, J.W.1    Van Veenendaal, W.2    Voorthuis, P.3    Weick, G.4    Hillen, F.C.5
  • 65
    • 84888198516 scopus 로고    scopus 로고
    • MK-801-induced and scopolamine-induced hyperactivity in rats neonatally treated chronically with MK-801
    • [65] Furuie, H., Yamada, K., Ichitani, Y., MK-801-induced and scopolamine-induced hyperactivity in rats neonatally treated chronically with MK-801. Behav. Pharmacol. 24 (2013), 678–683, 10.1097/FBP.0000000000000003.
    • (2013) Behav. Pharmacol. , vol.24 , pp. 678-683
    • Furuie, H.1    Yamada, K.2    Ichitani, Y.3
  • 66
    • 85007148366 scopus 로고    scopus 로고
    • Preclinical evaluation of the antipsychotic potential of the mGlu2-positive allosteric modulator JNJ-40411813
    • [66] Lavreysen, H., Langlois, X., Ver Donck, L., Nuñez, J.M.C., Pype, S., Lütjens, R., Megens, A., Preclinical evaluation of the antipsychotic potential of the mGlu2-positive allosteric modulator JNJ-40411813. Pharmacol. Res. Perspect., 3, 2015, e00097, 10.1002/prp2.97.
    • (2015) Pharmacol. Res. Perspect. , vol.3 , pp. e00097
    • Lavreysen, H.1    Langlois, X.2    Ver Donck, L.3    Nuñez, J.M.C.4    Pype, S.5    Lütjens, R.6    Megens, A.7
  • 67
    • 33748544640 scopus 로고    scopus 로고
    • Complexes of alkylene-linked tacrine dimers with Torpedo californica acetylcholinesterase: binding of Bis5-tacrine produces a dramatic rearrangement in the active-site gorge
    • [67] Rydberg, E.H., Brumshtein, B., Greenblatt, H.M., Wong, D.M., Shaya, D., Williams, L.D., Carlier, P.R., Pang, Y.-P., Silman, I., Sussman, J.L., Complexes of alkylene-linked tacrine dimers with Torpedo californica acetylcholinesterase: binding of Bis5-tacrine produces a dramatic rearrangement in the active-site gorge. J. Med. Chem. 49 (2006), 5491–5500, 10.1021/jm060164b.
    • (2006) J. Med. Chem. , vol.49 , pp. 5491-5500
    • Rydberg, E.H.1    Brumshtein, B.2    Greenblatt, H.M.3    Wong, D.M.4    Shaya, D.5    Williams, L.D.6    Carlier, P.R.7    Pang, Y.-P.8    Silman, I.9    Sussman, J.L.10
  • 69
    • 84886947382 scopus 로고    scopus 로고
    • Inhibition of cholinesterase and monoamine oxidase-B activity by Tacrine-Homoisoflavonoid hybrids
    • [69] Sun, Y., Chen, J., Chen, X., Huang, L., Li, X., Inhibition of cholinesterase and monoamine oxidase-B activity by Tacrine-Homoisoflavonoid hybrids. Bioorg. Med. Chem. 21 (2013), 7406–7417, 10.1016/j.bmc.2013.09.050.
    • (2013) Bioorg. Med. Chem. , vol.21 , pp. 7406-7417
    • Sun, Y.1    Chen, J.2    Chen, X.3    Huang, L.4    Li, X.5
  • 70
    • 0037413568 scopus 로고    scopus 로고
    • Specific targeting of acetylcholinesterase and butyrylcholinesterase recognition sites. Rational design of novel, selective, and highly potent cholinesterase inhibitors
    • [70] Savini, L., Gaeta, A., Fattorusso, C., Catalanotti, B., Campiani, G., Chiasserini, L., Pellerano, C., Novellino, E., McKissic, D., Saxena, A., Specific targeting of acetylcholinesterase and butyrylcholinesterase recognition sites. Rational design of novel, selective, and highly potent cholinesterase inhibitors. J. Med. Chem. 46 (2003), 1–4, 10.1021/jm0255668.
    • (2003) J. Med. Chem. , vol.46 , pp. 1-4
    • Savini, L.1    Gaeta, A.2    Fattorusso, C.3    Catalanotti, B.4    Campiani, G.5    Chiasserini, L.6    Pellerano, C.7    Novellino, E.8    McKissic, D.9    Saxena, A.10
  • 71
    • 26444566295 scopus 로고    scopus 로고
    • Regioselective alkylation of 3,4-dihydro-2H-pyran by xanthate-mediated free radical nonchain process
    • [71] Torres-Murro, J., Quintero, L., Sartillo-Piscil, F., Regioselective alkylation of 3,4-dihydro-2H-pyran by xanthate-mediated free radical nonchain process. Tetrahedron Lett. 46 (2005), 7691–7694, 10.1016/j.tetlet.2005.09.049.
    • (2005) Tetrahedron Lett. , vol.46 , pp. 7691-7694
    • Torres-Murro, J.1    Quintero, L.2    Sartillo-Piscil, F.3
  • 73
    • 2142770225 scopus 로고    scopus 로고
    • Investigations into the mechanism of lactamization of lactones yielding in a novel route to biologically active tryptamine derivatives
    • [73] Decker, M., Nguyen, T.T.H., Lehmann, J., Investigations into the mechanism of lactamization of lactones yielding in a novel route to biologically active tryptamine derivatives. Tetrahedron 60 (2004), 4567–4578, 10.1016/j.tet.2004.03.073.
    • (2004) Tetrahedron , vol.60 , pp. 4567-4578
    • Decker, M.1    Nguyen, T.T.H.2    Lehmann, J.3
  • 74
    • 0024332001 scopus 로고
    • Facile preparation of 2-imino tetrahydrofurans, pyrans and oxepans
    • [74] Alanine, A.I.D., Fishwick, C.W.G., Szantay, C., Facile preparation of 2-imino tetrahydrofurans, pyrans and oxepans. Tetrahedron Lett. 30 (1989), 6571–6572, 10.1016/S0040-4039(01)89024-9.
    • (1989) Tetrahedron Lett. , vol.30 , pp. 6571-6572
    • Alanine, A.I.D.1    Fishwick, C.W.G.2    Szantay, C.3
  • 75
    • 77949853380 scopus 로고    scopus 로고
    • Salicylic acid based small molecule inhibitor for the oncogenic src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2)
    • [75] Zhang, X., He, Y., Liu, S., Yu, Z., Jiang, Z.X., Yang, Z., Dong, Y., Nabinger, S.C., Wu, L., Gunawan, A.M., Wang, L., Chan, R.J., Zhang, Z.Y., Salicylic acid based small molecule inhibitor for the oncogenic src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2). J. Med. Chem. 53 (2010), 2482–2493, 10.1021/jm901645u.
    • (2010) J. Med. Chem. , vol.53 , pp. 2482-2493
    • Zhang, X.1    He, Y.2    Liu, S.3    Yu, Z.4    Jiang, Z.X.5    Yang, Z.6    Dong, Y.7    Nabinger, S.C.8    Wu, L.9    Gunawan, A.M.10    Wang, L.11    Chan, R.J.12    Zhang, Z.Y.13
  • 76
    • 84875431627 scopus 로고    scopus 로고
    • Ligand-optimized homology models of D1 and D2 dopamine receptors: application for virtual screening
    • [76] Kołaczkowski, M., Bucki, A., Feder, M., Pawłowski, M., Ligand-optimized homology models of D1 and D2 dopamine receptors: application for virtual screening. J. Chem. Inf. Model 53 (2013), 638–648, 10.1021/ci300413h.
    • (2013) J. Chem. Inf. Model , vol.53 , pp. 638-648
    • Kołaczkowski, M.1    Bucki, A.2    Feder, M.3    Pawłowski, M.4
  • 78
    • 0043123216 scopus 로고    scopus 로고
    • GeneSilico protein structure prediction meta-server
    • [78] Kurowski, M.A., Bujnicki, J.M., GeneSilico protein structure prediction meta-server. Nucleic Acids Res. 31 (2003), 3305–3307, 10.1093/nar/gkg557.
    • (2003) Nucleic Acids Res. , vol.31 , pp. 3305-3307
    • Kurowski, M.A.1    Bujnicki, J.M.2
  • 79
    • 32144432437 scopus 로고    scopus 로고
    • The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling
    • [79] Arnold, K., Bordoli, L., Kopp, J., Schwede, T., The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 22 (2006), 195–201, 10.1093/bioinformatics/bti770.
    • (2006) Bioinformatics , vol.22 , pp. 195-201
    • Arnold, K.1    Bordoli, L.2    Kopp, J.3    Schwede, T.4
  • 80
    • 84983032994 scopus 로고    scopus 로고
    • Sulfonyltetrahydro-3H-benzo(e)indole-8-amine compounds as 5-Hydroxytryptamine-6 ligands
    • US Patent 2005/0101596
    • [80] D.C. Cole, M. Asselin, Sulfonyltetrahydro-3H-benzo(e)indole-8-amine compounds as 5-Hydroxytryptamine-6 ligands, US Patent 2005/0101596, 2005.
    • (2015)
    • Cole, D.C.1    Asselin, M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.